E-LIB Suche - Ergebnisse für: Bondy, M. L.

1

Determinants of exposure to endocrine disruptors following ..:

Samon, S.M. ; Rohlman, D. ; Tidwell, L....
Environmental Research. 217 (2023) - p. 114867 , 2023

Link: https://doi.org/10.1016/..

2

Assessing the impact of cardiometabolic risk on ovarian can..:

Staples, J.N. ; Peres, L.C. ; Camacho, F....
Gynecologic Oncology. 159 (2020) - p. 157-158 , 2020

Link: https://doi.org/10.1016/..

3

Testing for causality between systematically identified ris..:

Howell, A. E. ; Robinson, J. W. ; Wootton, R. E....
BMC Cancer. 20 (2020) 1 - p. , 2020

Link: https://doi.org/10.1186/..

4

Tensile fatigue characterization of polyamide 66/carbon fib..:

Bondy, M. ; Rodgers, W. ; Altenhof, W.
Composites Part B: Engineering. 173 (2019) - p. 106984 , 2019

Link: https://doi.org/10.1016/..

5

Farmers' health and wellbeing in the context of changing fa..:

Cole, D ; Bondy, M
European Journal of Public Health. 29 (2019) Supplement_4 - p. , 2019

Link: https://doi.org/10.1093/..

6

Cardiovascular comorbidities and risk of ovarian carcinoma ..:

Staples, J.N. ; Peres, L.C. ; Camacho, F....
Gynecologic Oncology. 154 (2019) - p. 123 , 2019

Link: https://doi.org/10.1016/..

7

P13.06 Transcriptome-wide Mendelian randomization study to ..:

Robinson, J W ; Zheng, J ; Tscavachidis, S...
Neuro-Oncology. 21 (2019) Supplement_3 - p. iii63-iii63 , 2019

Link: https://doi.org/10.1093/..

8

BTC1.03Investigating the causal relevance of hypothesized r..:

Howell, A E ; Zheng, J ; Tsavachidis, S...
Neuro-Oncology. 20 (2018) suppl_3 - p. iii215-iii215 , 2018

Link: https://doi.org/10.1093/..

9

P04.72Using Mendelian randomization to find potential novel..:

Robinson, J W ; Zheng, J ; Tsavachidis, S...
Neuro-Oncology. 20 (2018) suppl_3 - p. iii296-iii297 , 2018

Link: https://doi.org/10.1093/..

10

An experimental study on the energy absorption characterist..:

Ghasemabadian, M. A. ; Kadkhodayan, M. ; Altenhof, W...
International Journal of Crashworthiness. 24 (2018) 3 - p. 272-285 , 2018

Link: https://doi.org/10.1080/..

11

OS05.6 Final risk model for Temozolomide (TMZ)-Myelotoxicit..:

Armstrong, T. S. ; Gilbert, M. R. ; Bondy, M....
Neuro-Oncology. 19 (2017) suppl_3 - p. iii10-iii10 , 2017

Link: https://doi.org/10.1093/..

12

THE GERIATRIC SUBSTANCE ABUSE RECOVERY PROGRAM (GSARP): SOL..:

Burack, O. ; Cimarolli, V.R. ; Poole-Dayan, G....
Innovation in Aging. 1 (2017) suppl_1 - p. 872-872 , 2017

Link: https://doi.org/10.1093/..

13

OS06.1 Genome-wide association study reveals specific diffe..:

Melin, B. S. ; Kinnersley, B. ; Ostrom, Q....
Neuro-Oncology. 19 (2017) suppl_3 - p. iii10-iii11 , 2017

Link: https://doi.org/10.1093/..

14

Response:

Bainbridge, M. ; Bondy, M. L.
JNCI Journal of the National Cancer Institute. 107 (2015) 8 - p. djv174-djv174 , 2015

Link: https://doi.org/10.1093/..

15

CN-21 * RISK MODELING FOR TEMOZOLOMIDE (TMZ)-MYELOTOXICITY ..:

Zhou, R. ; Scheurer, M. ; Vera-Bolanos, E....
Neuro-Oncology. 16 (2014) suppl 5 - p. v50-v50 , 2014

Link: https://doi.org/10.1093/..